Gladstone Institutional Advisory »

Checkpoint Therapeutics shares owned by Gladstone Institutional Advisory

Quarter-by-quarter ownership of Checkpoint Therapeutics (CKPT) shares owned by Gladstone Institutional Advisory from 13F filings

Historical chart of Gladstone Institutional Advisory investment in Checkpoint Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Checkpoint Therapeutics held by Gladstone Institutional Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Checkpoint Therapeutics by Gladstone Institutional Advisory

Quarter filed Position value Share count Share price at filing
2023-12-31 $23k 10k 2.29

More positions owned by Gladstone Institutional Advisory

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Wisdomtree Tr Floatng Rat Trea (USFR)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Actively Managed Etf Ultra Shrt Dur (GSY)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Microsoft Corporation (MSFT)
First Tr Exchng Traded Fd Vi Cboe Vest Us Eq (BUFR)
Amazon (AMZN)
First Tr Exchange-traded Lng Dur Oprtun (LGOV)
JPMorgan Chase & Co. (JPM)
NVIDIA Corporation (NVDA)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)

View all positions for Gladstone Institutional Advisory

Top funds holding Checkpoint Therapeutics

Vanguard Group
National Asset Management
Advisor Group Holdings
D. E. Shaw & Co
Pvg Asset Management
Citadel Advisors
Legacy Wealth Asset Management
Royal Bank of Canada
Park Avenue Securities
Wealth Enhancement Advisory Services
Jane Street
Lindbrook Capital
Rsm Us Wealth Management
Wells Fargo & Company
Emfo

View all funds holding Checkpoint Therapeutics